{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-25-000007","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.779571+00:00","generated_at":"2026-05-28T03:42:15.335707+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Immunovant announces $450M PIPE at $20/share to advance pipeline","bullets":["Agreed to sell 22.5M shares at $20/share to three institutional investors, including Roivant Sciences.","Gross proceeds expected ~$450M; closing on or about Jan 15, 2025 subject to customary conditions.","Proceeds to fund development pipeline (lead asset IMVT-1402), working capital, and general corporate purposes.","Shares sold in private placement exempt from registration; resale registration to be filed with SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-25-000007","json":"https://secwatch.observer/filing/0001764013-25-000007.json","markdown":"https://secwatch.observer/filing/0001764013-25-000007.md","text":"https://secwatch.observer/filing/0001764013-25-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000007/0001764013-25-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000007/imvt-20250113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:42:15.335707+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}